# Duloxetine Versus Paroxetine for Major Depression

> **NCT00489775** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 480 (—)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT00489775
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 480 (—)
- **Last updated:** 2007-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489775, "Duloxetine Versus Paroxetine for Major Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00489775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*